Fosrolapitant and Palonosetron Hydrochloride for Injection combined with dexamethasone acetate: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Fosrolapitant and Palonosetron Hydrochloride for Injection combined with dexamethasone acetate

• The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
  NCT07617246 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Fosrolapitant and Palonosetron Hydrochloride for Injection combined with dexamethasone acetate?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.